Bay Area pain management clinics can help when chronic pain, injuries or post-surgical discomfort persist. These top pain clinic doctors stay on the cutting edge of scientific and medical ...

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

Boston Scientific said on Wednesday it has discontinued sales of its heart device in the European Union and will not seek approval in the U.S. and other markets due to increased clinical and ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other stocks that Jim Cramer discusses. Back in 2024, on May 16, a caller asked about ...

The company will compete with a device Boston Scientific acquired for $850 million.

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the July 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BSX ...

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...

TFC Financial Management Inc. raised its holdings in Boston Scientific by 308.8% during the ... movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary ...

We provide practical advice for how to facilitate pain self-management in clinical practice. Finally, we discuss scientific caveats and practical obstacles to improvement, suggesting possible pathways ...

Boston Scientific ... rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment ...